Formulation

Pipelines are changing, and chemical complexity is on the rise. What can pharma manufacturers do about it?

Could dry vaccines help improve global access to the latest vaccine technologies?

What does the future hold for lipid nanoparticles?

Watch our special roundtable to learn about pharma industry trends and events post-COVID-19.

From chasing drug lords to advising US presidents, it’s fair to say Robert Pinco has enjoyed a varied career.

Researchers examine how changes in the gut – including those that result from posture – affect drug bioavailability.

Keith Horspool reflects on the efforts that led the FDA to launch its pilot review program for novel excipients

Determining full versus empty capsids remains a key challenge with adeno-associated viral vectors.

Exploring the potential of self-amplifying RNA and circular RNA in the future of drug development.

As new treatment modalities emerge, drug developers are turning to synthetic chemistry – and partners like Veranova.